Abstract

Epithelial plasticity has been suggested in lungs of mice following genetic depletion of stem cells but is of unknown physiological relevance. Viral infection and chronic lung disease share similar pathological features of stem cell loss in alveoli, basal cell (BC) hyperplasia in small airways, and innate immune activation, that contribute to epithelial remodeling and loss of lung function. We show that a subset of distal airway secretory cells, intralobar serous (IS) cells, are activated to assume BC fates following influenza virus infection. Injury-induced hyperplastic BC (hBC) differ from pre-existing BC by high expression of IL-22Ra1 and undergo IL-22-dependent expansion for colonization of injured alveoli. Resolution of virus-elicited inflammation results in BC to IS re-differentiation in repopulated alveoli, and increased local expression of protective antimicrobial factors, but fails to restore normal alveolar epithelium responsible for gas exchange.

After respiratory viral infection and in fibrotic lung disease, repair and remodeling processes particularly affect airway basal cell (BC) and alveolar epithelial cell populations. Here, using single cell transcriptomics and lineage tracing, the authors characterize this process and define roles for innate immune activation in the regulation of BC fate and alveolar remodeling.

Details

Title
Epithelial plasticity and innate immune activation promote lung tissue remodeling following respiratory viral infection
Author
Beppu, Andrew K. 1 ; Zhao, Juanjuan 1 ; Yao, Changfu 1   VIAFID ORCID Logo  ; Carraro, Gianni 1   VIAFID ORCID Logo  ; Israely, Edo 2 ; Coelho, Anna Lucia 3 ; Drake, Katherine 1   VIAFID ORCID Logo  ; Hogaboam, Cory M. 3   VIAFID ORCID Logo  ; Parks, William C. 3 ; Kolls, Jay K. 4   VIAFID ORCID Logo  ; Stripp, Barry R. 1   VIAFID ORCID Logo 

 Cedars-Sinai Medical Center, Department of Medicine, Women’s Guild Lung Institute, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905); Cedars-Sinai Medical Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905); Cedars-Sinai Medical Center, Department of Medicine, Regenerative Medicine Institute, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905) 
 Cedars-Sinai Medical Center, Department of Medicine, Regenerative Medicine Institute, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905) 
 Cedars-Sinai Medical Center, Department of Medicine, Women’s Guild Lung Institute, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905); Cedars-Sinai Medical Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Los Angeles, USA (GRID:grid.50956.3f) (ISNI:0000 0001 2152 9905) 
 School of Medicine, Tulane Center for Translational Research in Infection and Inflammation, New Orleans, USA (GRID:grid.411417.6) (ISNI:0000 0004 0443 6864) 
Pages
5814
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2866248725
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.